These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 38744274)

  • 21. Soluble TREM2 levels associate with conversion from mild cognitive impairment to Alzheimer's disease.
    Zhao A; Jiao Y; Ye G; Kang W; Tan L; Li Y; Deng Y; Liu J;
    J Clin Invest; 2022 Dec; 132(24):. PubMed ID: 36519540
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Soluble TREM2 is elevated in Parkinson's disease subgroups with increased CSF tau.
    Wilson EN; Swarovski MS; Linortner P; Shahid M; Zuckerman AJ; Wang Q; Channappa D; Minhas PS; Mhatre SD; Plowey ED; Quinn JF; Zabetian CP; Tian L; Longo FM; Cholerton B; Montine TJ; Poston KL; Andreasson KI
    Brain; 2020 Mar; 143(3):932-943. PubMed ID: 32065223
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Early increase of CSF sTREM2 in Alzheimer's disease is associated with tau related-neurodegeneration but not with amyloid-β pathology.
    Suárez-Calvet M; Morenas-Rodríguez E; Kleinberger G; Schlepckow K; Araque Caballero MÁ; Franzmeier N; Capell A; Fellerer K; Nuscher B; Eren E; Levin J; Deming Y; Piccio L; Karch CM; Cruchaga C; Shaw LM; Trojanowski JQ; Weiner M; Ewers M; Haass C;
    Mol Neurodegener; 2019 Jan; 14(1):1. PubMed ID: 30630532
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cerebrospinal fluid synaptosomal-associated protein 25 is a key player in synaptic degeneration in mild cognitive impairment and Alzheimer's disease.
    Zhang H; Therriault J; Kang MS; Ng KP; Pascoal TA; Rosa-Neto P; Gauthier S;
    Alzheimers Res Ther; 2018 Aug; 10(1):80. PubMed ID: 30115118
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Myoclonus status revealing COVID 19 infection.
    Ben Mohamed D; Zouari R; Ketata J; Nabli F; Blel S; Ben Sassi S
    Seizure; 2023 Jan; 104():12-14. PubMed ID: 36446232
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A Longitudinal Study of COVID-19 Sequelae and Immunity: Baseline Findings.
    Sneller MC; Liang CJ; Marques AR; Chung JY; Shanbhag SM; Fontana JR; Raza H; Okeke O; Dewar RL; Higgins BP; Tolstenko K; Kwan RW; Gittens KR; Seamon CA; McCormack G; Shaw JS; Okpali GM; Law M; Trihemasava K; Kennedy BD; Shi V; Justement JS; Buckner CM; Blazkova J; Moir S; Chun TW; Lane HC
    Ann Intern Med; 2022 Jul; 175(7):969-979. PubMed ID: 35605238
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Persistent neurologic symptoms and cognitive dysfunction in non-hospitalized Covid-19 "long haulers".
    Graham EL; Clark JR; Orban ZS; Lim PH; Szymanski AL; Taylor C; DiBiase RM; Jia DT; Balabanov R; Ho SU; Batra A; Liotta EM; Koralnik IJ
    Ann Clin Transl Neurol; 2021 May; 8(5):1073-1085. PubMed ID: 33755344
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Microglial activation, tau and amyloid deposition in TREM2 p.R47H carriers and mild cognitive impairment patients: a multi-modal/multi-tracer PET/MRI imaging study with influenza vaccine immune challenge.
    Cousins O; Schubert JJ; Chandra A; Veronese M; Valkimadi P; Creese B; Khan Z; Arathimos R; Hampshire A; Rosenzweig I; Ballard C; Corbett A; Aasland D; Velayudhan L; O'Neill M; Collier D; Awais R; Sander K; Årstad E; Howes O; Turkheimer F; Hodges A
    J Neuroinflammation; 2023 Nov; 20(1):272. PubMed ID: 37990275
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Structural magnetic resonance imaging for the early diagnosis of dementia due to Alzheimer's disease in people with mild cognitive impairment.
    Lombardi G; Crescioli G; Cavedo E; Lucenteforte E; Casazza G; Bellatorre AG; Lista C; Costantino G; Frisoni G; Virgili G; Filippini G
    Cochrane Database Syst Rev; 2020 Mar; 3(3):CD009628. PubMed ID: 32119112
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Encephalopathies Associated With Severe COVID-19 Present Neurovascular Unit Alterations Without Evidence for Strong Neuroinflammation.
    Bernard-Valnet R; Perriot S; Canales M; Pizzarotti B; Caranzano L; Castro-Jiménez M; Epiney JB; Vijiala S; Salvioni-Chiabotti P; Anichini A; Salerno A; Jaton K; Vaucher J; Perreau M; Greub G; Pantaleo G; Du Pasquier RA
    Neurol Neuroimmunol Neuroinflamm; 2021 Jul; 8(5):. PubMed ID: 34135107
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Neurological Manifestations of COVID-19 Feature T Cell Exhaustion and Dedifferentiated Monocytes in Cerebrospinal Fluid.
    Heming M; Li X; Räuber S; Mausberg AK; Börsch AL; Hartlehnert M; Singhal A; Lu IN; Fleischer M; Szepanowski F; Witzke O; Brenner T; Dittmer U; Yosef N; Kleinschnitz C; Wiendl H; Stettner M; Meyer Zu Hörste G
    Immunity; 2021 Jan; 54(1):164-175.e6. PubMed ID: 33382973
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cerebrospinal fluid soluble TREM2 levels in frontotemporal dementia differ by genetic and pathological subgroup.
    Woollacott IOC; Nicholas JM; Heslegrave A; Heller C; Foiani MS; Dick KM; Russell LL; Paterson RW; Keshavan A; Fox NC; Warren JD; Schott JM; Zetterberg H; Rohrer JD
    Alzheimers Res Ther; 2018 Aug; 10(1):79. PubMed ID: 30111356
    [TBL] [Abstract][Full Text] [Related]  

  • 33. SARS-CoV-2-Associated Acute Hemorrhagic, Necrotizing Encephalitis (AHNE) Presenting with Cognitive Impairment in a 44-Year-Old Woman without Comorbidities: A Case Report.
    Ghosh R; Dubey S; Finsterer J; Chatterjee S; Ray BK
    Am J Case Rep; 2020 Aug; 21():e925641. PubMed ID: 32799213
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Single-Cell Transcriptome Analysis Highlights a Role for Neutrophils and Inflammatory Macrophages in the Pathogenesis of Severe COVID-19.
    Shaath H; Vishnubalaji R; Elkord E; Alajez NM
    Cells; 2020 Oct; 9(11):. PubMed ID: 33138195
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long COVID in a prospective cohort of home-isolated patients.
    Blomberg B; Mohn KG; Brokstad KA; Zhou F; Linchausen DW; Hansen BA; Lartey S; Onyango TB; Kuwelker K; Sævik M; Bartsch H; Tøndel C; Kittang BR; ; Cox RJ; Langeland N
    Nat Med; 2021 Sep; 27(9):1607-1613. PubMed ID: 34163090
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cerebrospinal Fluid C-C Motif Chemokine Ligand 2 Correlates with Brain Atrophy and Cognitive Impairment in Alzheimer's Disease.
    Kimura A; Yoshikura N; Hayashi Y; Inuzuka T
    J Alzheimers Dis; 2018; 61(2):581-588. PubMed ID: 29171996
    [TBL] [Abstract][Full Text] [Related]  

  • 37. CSF sTREM2 in delirium-relation to Alzheimer's disease CSF biomarkers Aβ42, t-tau and p-tau.
    Henjum K; Quist-Paulsen E; Zetterberg H; Blennow K; Nilsson LNG; Watne LO
    J Neuroinflammation; 2018 Nov; 15(1):304. PubMed ID: 30390679
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Post-acute sequelae of COVID-19 in a non-hospitalized cohort: Results from the Arizona CoVHORT.
    Bell ML; Catalfamo CJ; Farland LV; Ernst KC; Jacobs ET; Klimentidis YC; Jehn M; Pogreba-Brown K
    PLoS One; 2021; 16(8):e0254347. PubMed ID: 34347785
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Long COVID brain fog and muscle pain are associated with longer time to clearance of SARS-CoV-2 RNA from the upper respiratory tract during acute infection.
    Antar AAR; Yu T; Demko ZO; Hu C; Tornheim JA; Blair PW; Thomas DL; Manabe YC
    Front Immunol; 2023; 14():1147549. PubMed ID: 37187756
    [TBL] [Abstract][Full Text] [Related]  

  • 40. CSF progranulin increases in the course of Alzheimer's disease and is associated with sTREM2, neurodegeneration and cognitive decline.
    Suárez-Calvet M; Capell A; Araque Caballero MÁ; Morenas-Rodríguez E; Fellerer K; Franzmeier N; Kleinberger G; Eren E; Deming Y; Piccio L; Karch CM; Cruchaga C; Paumier K; Bateman RJ; Fagan AM; Morris JC; Levin J; Danek A; Jucker M; Masters CL; Rossor MN; Ringman JM; Shaw LM; Trojanowski JQ; Weiner M; Ewers M; Haass C; ;
    EMBO Mol Med; 2018 Dec; 10(12):. PubMed ID: 30482868
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.